We found that tumor infiltrated CD8+T cells were significantly increased 4 weeks after SNCP-125I brachytherapy, while CD4+T cell tumor infiltration showed no change (p=0.043, Figures 10C, D and Supplemental Figure 7B). This evidence concerns the gene CD8A and neoplasm.